Search for: "AMGEN INC." Results 521 - 540 of 707
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Feb 2011, 3:32 pm
§ 282, or the "rebuttable presumption that different claims are of different scope," Amgen Inc. v. [read post]
18 Feb 2011, 4:11 pm by Lawrence B. Ebert
§ 282, or the “rebuttable presumption that different claims are of different scope,” Amgen Inc. v. [read post]
20 Jan 2011, 1:32 pm by California Stem Cell Report
The California stem cell agency today named Ellen Feigal, an executive at Amgen, Inc., to the new position of vice president for research and development. [read post]
8 Dec 2010, 2:20 am by Marie Louise
Allergan, Inc (Docket Report) Products Enbrel (Etanercept) – Israel: Patent status in question, in need of legislative fix (America-Israel Patent Law) Fabrazyme (Alpha-galactosidase) – US: Statements by KEI and others on NIH rejection of Fabrazyme march-in request (KEI) Intuniv (Guanfacine) – US: Impax confirms patent challenge relating to Intuniv (GenericsWeb) Lovenox (Enoxaparin) – US: Momenta sues Teva over claims relating to ways of manufacturing and analysing… [read post]
29 Nov 2010, 8:00 am by DJ Ringquist
Choate also serves as a director of Amgen, Inc. and Van Kampen Mutual Funds. [read post]
24 Nov 2010, 8:22 am by Stefanie Levine
Patent No. 7,511,043 owned by Amgen and entitled FXR MODULATIONS. [read post]
24 Nov 2010, 8:22 am by Stefanie Levine
Patent No. 7,511,043 owned by Amgen and entitled FXR MODULATIONS. [read post]
31 Aug 2010, 10:01 pm by Kelly
Apotex Inc. et al (Docket Report) Lovenox (Enoxaparin) – US: DC District Court denies preliminary injunction in generic Lovenox case; Is the juice worth the squeeze for Sanofi to appeal? [read post]